UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Baseline Large‐Scale Network Dynamics Associated with Disease Progression in Huntington's Disease

Movement disorders, 2024-01, Vol.39 (1), p.197-203

2024

Link zum Volltext

Verfügbarkeit prüfen

Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease

Parkinsonism & related disorders, 2017-11, Vol.44, p.95-100

2017

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment

Movement disorders, 2013-09, Vol.28 (10), p.1376-1383

2013

Link zum Volltext

Verfügbarkeit prüfen

Divergent cognitive trajectories in early stage Huntington's disease: A 3‐year longitudinal study

European journal of neurology, 2023-07, Vol.30 (7), p.1871-1879

2023

Link zum Volltext

Verfügbarkeit prüfen

Increased cerebral FDG‐PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia

Journal of neuroendocrinology, 2021-01, Vol.33 (1), p.e12910-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia

BMJ open diabetes research & care, 2020-07, Vol.8 (1), p.e001516

2020

Link zum Volltext

Verfügbarkeit prüfen

CLU rs11136000 promotes early cognitive decline in Parkinson's disease

Movement disorders, 2020-03, Vol.35 (3), p.508-513

2020

Link zum Volltext

Verfügbarkeit prüfen

Structural and metabolic brain correlates of apathy in Huntington's disease

Movement disorders, 2018-07, Vol.33 (7), p.1151-1159

2018

Link zum Volltext

Verfügbarkeit prüfen

Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease

Neurobiology of disease, 2019-04, Vol.124, p.29-35

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia

The journal of clinical endocrinology and metabolism, 2021-02, Vol.106 (2), p.450-458

2021

Link zum Volltext

Verfügbarkeit prüfen

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

Annals of neurology, 2019-11, Vol.86 (5), p.762-769

2019

Link zum Volltext

Verfügbarkeit prüfen

Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis

PloS one, 2015-08, Vol.10 (8), p.e0136786-e0136786

2015

Link zum Volltext

Verfügbarkeit prüfen

Preservation of brain metabolism in recently diagnosed Parkinson’s impulse control disorders

European journal of nuclear medicine and molecular imaging, 2020-08, Vol.47 (9), p.2165-2174

2020

Link zum Volltext

Verfügbarkeit prüfen

Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing

The Journal of neuroscience, 2014-04, Vol.34 (17), p.5918-5926

2014

Link zum Volltext

Verfügbarkeit prüfen

Response to letter: “Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease”

Journal of the neurological sciences, 2022-07, Vol.438, p.120272-120272, Article 120272

2022

Link zum Volltext

Verfügbarkeit prüfen

Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers

Annals of neurology, 2022-12, Vol.92 (6), p.974-984

2022

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease

Frontiers in neurology, 2022-06, Vol.13, p.866502-866502

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of an alternative version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS)

Parkinsonism & related disorders, 2017-10, Vol.43, p.73-77

2017

Link zum Volltext

Verfügbarkeit prüfen

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline

Frontiers in neurology, 2018-05, Vol.9, p.394-394

2018

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

Annals of neurology, 2020-07, Vol.88 (1), p.205-205

2020

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

Parkinsonism & related disorders, 2020-05, Vol.74, p.43-49

2020

Link zum Volltext

Verfügbarkeit prüfen

Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease

Movement disorders, 2021-09, Vol.36 (9), p.2162-2172

2021

Link zum Volltext

Verfügbarkeit prüfen

Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease

Neurobiology of aging, 2021-01, Vol.97, p.120-128

2021

Link zum Volltext

Verfügbarkeit prüfen

Apathy in Parkinson's Disease: More Than Just Executive Dysfunction

Journal of the International Neuropsychological Society, 2013-05, Vol.19 (5), p.571-582

2013

Link zum Volltext

Verfügbarkeit prüfen

Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?

Journal of Neural Transmission, 2011-08, Vol.118 (8), p.1185-1190

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(103)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Baseline Large‐Scale Network Dynamics Associated with Disease Progression in Huntington's Disease

Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease

Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment

Divergent cognitive trajectories in early stage Huntington's disease: A 3‐year longitudinal study

Increased cerebral FDG‐PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia

Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia

CLU rs11136000 promotes early cognitive decline in Parkinson's disease

Structural and metabolic brain correlates of apathy in Huntington's disease

Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease

Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis

Preservation of brain metabolism in recently diagnosed Parkinson’s impulse control disorders

Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing

Response to letter: “Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease”

Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease

Development and validation of an alternative version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS)

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline

Corrigendum: Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease

Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease

Apathy in Parkinson's Disease: More Than Just Executive Dysfunction

Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?

Suchergebnisse filtern